Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Bridgebio Pharma
Bridgebio Pharma
(BBIO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Acoramidis
amyloidosis
,
cardiomyopathies
,
polyneuropathies
,
familial amyloid neuropathies
,
heart diseases
,
amyloid neuropathies
,
alzheimer disease
,
familial amyloidosis
Alfacalcidol
mucopolysaccharidoses
,
mucopolysaccharidosis i
,
lysosomal storage diseases
,
cognitive dysfunction
Aspartame
postoperative pain
Bevifimod
diabetes mellitus
,
diabetic neuropathies
,
chronic pain
,
attention deficit disorder with hyperactivity
Retinol
chronic kidney failure
,
albuminuria
,
asthma
,
psoriasis
,
type 2 diabetes mellitus
,
diabetes mellitus
,
inflammation
,
breast feeding
,
lactation
,
gastric bypass
,
chronic renal insufficiency
,
secondary hyperparathyroidism
,
kidney diseases
,
hyperparathyroidism
,
neoplasm metastasis
,
diabetic nephropathies
,
renal dialysis
,
vitamin d deficiency
,
cardiovascular diseases
,
dialysis
,
hypercalcemia
,
metabolic bone diseases
,
sepsis
,
septic shock
,
toxemia
,
kidney transplantation
,
pulmonary fibrosis
,
healthy diet
Globulin, immune
rheumatoid arthritis
Alxn2060
heart diseases
,
cardiomyopathies
,
amyloidosis
,
familial amyloid neuropathies
,
polyneuropathies
,
alzheimer disease
,
familial amyloidosis
VT30
congenital abnormalities
,
vascular malformations
,
lymphangioma
,
lymphatic abnormalities
,
myocardial infarction
,
sudden death cardiac
,
death
,
tachycardia
,
infarction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use